Trials / Completed
CompletedNCT06196723
Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites
TIPS Improve Survival in Patients With Cirrhosis and Recurrent Ascites: a Multicenter Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 462 (actual)
- Sponsor
- Tang-Du Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Currently, there is limited evidence regarding the survival benefit of early transjugular intrahepatic portal shunt (TIPS) placement in patients with cirrhosis and recurrent ascites. This observational study aimed to assess whether early TIPS improves the survival of patients with advanced cirrhosis and recurrent ascites. We will compare large volume paracenteses plus albumin (LVP+A） to see if TIPS improves the survival of patients with advanced cirrhosis and recurrent ascites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | transjugular intrahepatic portal shunt | TIPS was performed by experienced clinicians in the Gastroenterology/Hepatology Department according to standard operating procedures, utilizing 8 mm or 10 mm expanded polytetrafluoroethylene-covered stents at the discretion of the local physician. |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2024-02-01
- Completion
- 2024-02-01
- First posted
- 2024-01-09
- Last updated
- 2024-08-27
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06196723. Inclusion in this directory is not an endorsement.